Exagen Inc(NASDAQ:XGN) 
Exagen Inc. develops and commercializes various testing products based on its Cell-Bound Complement Activation Products technology under the AVISE brand in the United States. It enables rheumatologists to enhance care for patients through the diagnosis, prognosis, and monitoring of complex autoimmun...
Website: http://www.exagen.com
Founded: 2002
IPO Price: $14 (Sep 19, 2019)
Full Time Employees: 153
CEO: Fortunato Ron Rocca
Sector: Healthcare
Industry: Diagnostics & Research
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 3.97
H 4.15
L 3.83
C 4.03
V 48,948
10EMA 4.03
20EMA 4.03
60EMA 4.03
120EMA 4.03
250EMA 4.03